Cohen J. The scientific challenge of hepatitis C[J].Science, 1999,285: 26-30.
[2]
Popescu C, Gliga S and Arama V. Trends in hepatitis C virus infection therapy: protease inhibitors a step forward in the era of direct acting antivirals [J]. Rom J Intern Med, 2013, 50(2): 117-127.
[3]
Wu LH, Zhang C,Shan BE,et al. CD40L-expressing mouse colon cancer colon26 vaccine enhances DC activities[J]. Chin J Cancer Biother, 2010, (5):514-520. (In Chinese)
Zhang LX, Tang YC, Akbulut H, et al. An adenoviral vector cancer vaccine that delivers a tumor-associated antigen-CD40-ligand fusion protein to dendritic cells [J].PNAS, 2003, 100(25):15101-15106.
[6]
Berlec A, Ravnikar M, Strukelj B. Lactic acid bacteria as oral delivery systems for biomolecules[J]. Pharmazie, 2012, 67(11):891-898.
